CONMED Corporation (CNMD)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 54.59% | 54.31% | 53.97% | 54.33% | 54.50% | 53.56% | 53.51% | 53.76% | 54.64% | 55.70% | 56.21% | 56.41% | 56.21% | 55.35% | 55.09% | 53.29% | 53.37% | 53.37% | 53.22% | 54.95% |
| Operating profit margin | 15.15% | 14.63% | 11.99% | 11.34% | 7.67% | 4.40% | 2.43% | 2.25% | 3.40% | 6.92% | 9.02% | 9.34% | 10.86% | 9.82% | 10.21% | 6.01% | 5.33% | 5.62% | 4.68% | 8.48% |
| Pretax margin | 12.49% | 12.45% | 9.72% | 8.23% | 6.49% | 2.53% | 2.20% | -7.82% | -6.78% | -2.87% | -2.78% | 7.92% | 7.23% | 5.76% | 5.81% | 0.89% | 0.19% | 0.61% | -0.29% | 3.86% |
| Net profit margin | 10.15% | 10.24% | 7.74% | 6.53% | 5.18% | 4.96% | 7.75% | -8.53% | -7.71% | -7.74% | -10.93% | 6.63% | 6.19% | 6.29% | 5.53% | 1.53% | 1.10% | 0.04% | 0.05% | 3.53% |
CONMED Corporation's profitability ratios show positive trends in recent quarters. The gross profit margin has been consistently increasing, indicating the company's ability to generate more profit from sales after accounting for the cost of goods sold. Similarly, the operating profit margin has shown notable improvements, reflecting the company's efficiency in managing operating expenses and generating profits from its core business activities.
The pretax margin has also exhibited an upward trajectory, implying that CONMED has been able to effectively control its pre-tax expenses and increase its profitability before accounting for taxes. Additionally, the net profit margin has shown improvement, although it experienced a decline in certain periods. This suggests that the company has been successful in managing its overall expenses and generating profits that benefit shareholders.
Overall, CONMED Corporation's profitability ratios indicate a positive trend in its financial performance, demonstrating the company's ability to increase profits and enhance shareholder value over the analyzed periods.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 8.57% | 8.13% | 6.68% | 6.19% | 4.15% | 2.21% | 1.19% | 1.07% | 1.55% | 3.22% | 4.54% | 5.33% | 6.21% | 5.54% | 5.67% | 3.03% | 2.63% | 2.82% | 2.36% | 4.61% |
| Return on assets (ROA) | 5.74% | 5.69% | 4.31% | 3.57% | 2.80% | 2.49% | 3.80% | -4.04% | -3.51% | -3.61% | -5.50% | 3.79% | 3.54% | 3.55% | 3.07% | 0.77% | 0.54% | 0.02% | 0.02% | 1.91% |
| Return on total capital | 20.24% | 19.86% | 15.57% | 13.73% | 8.98% | 3.88% | 3.18% | -10.26% | -8.94% | -3.95% | -2.13% | 10.99% | 12.27% | 11.09% | 12.08% | 6.88% | 6.53% | 7.21% | 4.78% | 10.14% |
| Return on equity (ROE) | 13.76% | 14.12% | 11.18% | 9.64% | 7.73% | 7.28% | 11.32% | -12.46% | -10.81% | -11.55% | -16.93% | 8.57% | 7.96% | 8.24% | 7.27% | 1.85% | 1.34% | 0.05% | 0.06% | 4.78% |
CONMED Corporation's profitability ratios show fluctuations over the years.
- Operating return on assets (Operating ROA) improved from around 2% to over 8% between March 31, 2020, and December 31, 2024, indicating an increasing efficiency in generating operating income from its assets.
- Return on assets (ROA) started from a very low point in June 30, 2020, but gradually recovered and improved to around 6% by December 31, 2024, reflecting a better ability to generate profits from its total assets.
- Return on total capital fluctuated significantly, with negative values in some quarters up to June 30, 2022, but then steadily increased to around 20% by December 31, 2024, showing a stronger return on the total invested capital.
- Return on equity (ROE) also exhibited a wide range of fluctuations, including negative values for some periods, but overall saw an upward trend to around 14% by December 31, 2024, indicating an improvement in the return to shareholders' equity.
Overall, CONMED Corporation showed varied profitability performance over the period, with some fluctuations and challenges in profitability ratios, but notable improvements toward the end of the period.